Linden Thomas Advisory Services’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.39M | Buy |
32,523
+16,631
| +105% | +$4.29M | 0.92% | 7 |
|
|
2025
Q1 | $3.56M | Buy |
15,892
+515
| +3% | +$115K | 0.46% | 44 |
|
|
2024
Q4 | $3.52M | Buy |
15,377
+462
| +3% | +$106K | 0.45% | 46 |
|
|
2024
Q3 | $3.64M | Buy |
14,915
+195
| +1% | +$47.6K | 0.5% | 35 |
|
|
2024
Q2 | $2.82M | Buy |
14,720
+8,070
| +121% | +$1.54M | 0.44% | 47 |
|
|
2024
Q1 | $1.32M | Buy |
6,650
+160
| +2% | +$31.7K | 0.21% | 201 |
|
|
2023
Q4 | $1.12M | Buy |
6,490
+105
| +2% | +$18.1K | 0.21% | 215 |
|
|
2023
Q3 | $944K | Sell |
6,385
-3,332
| -34% | -$493K | 0.21% | 206 |
|
|
2023
Q2 | $2.12M | Buy |
9,717
+320
| +3% | +$69.9K | 0.47% | 41 |
|
|
2023
Q1 | $2.06M | Buy |
9,397
+169
| +2% | +$37K | 0.51% | 40 |
|
|
2022
Q4 | $1.92M | Buy |
+9,228
| New | +$1.92M | 0.54% | 34 |
|